ASP Isotopes Inc. ASPI

Healthcare SIC 2890 - Miscellaneous Chemical Products Nasdaq

We are an advanced materials company dedicated to the development of a differentiated isotope enrichment platform to strengthen global supply chain access to critical materials used in nuclear medicine, next-generation semiconductors, and nuclear energy. In addition, in January 2026, we acquired Renergen, which is South Africa's leading onshore natural gas explorer and the first integrated producer of both liquid helium and LNG (as discussed further below). Our proprietary enrichment technologies, the Aerodynamic Separation Process ("ASP technology") and Quantum Enrichment technology ("QE technology"), are designed to enable the production of isotopes for a range of industrial and advanced technology applications. Our initial focus with respect to our isotope enrichment platform is on the production and commercialization of enriched Carbon-14 ("C-14"), Silicon-28 ("Si-28") and Ytterbium-176 ("Yb-176").

Last close 4.20 2026-09-04
Market cap $643.9M 2026-06-30 share count
52-week range 3.51 - 14.49

Valuation FY2025 figures against the last close

P/S27.0x
P/E
P/FCF
EV/EBITDA
Dividend yield0.0%
Diluted EPS-2.11

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021
Revenue $23.8M$4.1M$433.0K$0
Cost of revenue $20.4M$2.5M$294.1K$0
Gross profit $3.4M$1.6M$139.0K$0
R&D $12.4M$3.1M$764.6K$1.3M
SG&A $48.2M$24.8M$15.4M$3.8M
Total operating expenses $63.3M$28.0M$16.2M$5.1M
Operating income -$59.9M-$26.4M-$16.0M-$5.1M
Interest expense $575.0K$259.0K$118.5K$0
Pre-tax income -$159.6M-$32.3M-$16.3M-$4.9M
Income tax $282.0K$111.0K$6.1K$0
Net income -$159.8M-$32.4M-$16.3M-$4.9M
EPS, basic -2.11-0.63-0.49-0.18
EPS, diluted -2.11-0.63-0.49
Shares, diluted (wtd. avg.) $83.0M$55.7M$33.1M$26.8M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021
Cash and equivalents $285.6M$61.9M$7.9M$2.4M$3.0M
Short-term investments $47.7M$0
Inventory $1.1M$66.0K$0
Total current assets $399.9M$65.7M$10.5M$3.3M$3.2M
Property, plant and equipment $33.5M$22.4M$10.7M$8.2M$3.0M
Goodwill $8.6M$3.2M$3.3M$0
Other intangibles $1.5M
Total assets $498.0M$94.3M$27.5M$12.5M$7.1M
Accounts payable $5.8M$1.0M$2.0M$354.0K$59.7K
Short-term debt $12.9M$939.0K
Total current liabilities $32.7M$7.1M$5.7M$1.9M$303.4K
Long-term debt $1.5M$1.4M
Total liabilities $235.1M$43.2M$8.7M$2.7M$1.1M
Retained earnings -$231.3M-$56.2M-$23.8M-$7.6M-$2.6M
Total equity $204.2M$47.9M$18.8M$9.8M$6.0M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021
Operating cash flow -$37.8M-$16.7M-$5.4M-$2.9M
Depreciation and amortisation $1.9M$471.0K$37.4K$0
Stock-based compensation $16.0M$8.6M$8.7M$2.0M
Capital expenditure $9.7M$9.7M$2.3M$4.5M
Investing cash flow -$110.8M-$11.4M-$2.5M-$4.5M
Financing cash flow $371.6M$82.5M$13.4M$6.6M
Dividends paid $0$2.8M$0

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-197329.

Others in SIC 2890

TickerCompanyMarket capP/ERevenue growth
ESI Element Solutions Inc $8.77B 45.6x 3.8%
CBT CABOT CORP $4.21B 13.5x -7.0%
WDFC WD 40 CO $2.79B 31.0x 5.0%
FTK FLOTEK INDUSTRIES INC/CN/ $852.6M 28.0x 26.9%
OEC Orion S.A. $344.2M -3.8%
ARQ Arq, Inc. $100.4M 10.4%
FSI FLEXIBLE SOLUTIONS INTERNATIONAL INC $73.6M 96.0x 0.7%
ZTEK Zentek Ltd.